Buprenorphine in the United States: Motives for abuse, misuse, and diversion

Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of substance abuse treatment 2019-09, Vol.104, p.148-157
Hauptverfasser: Chilcoat, Howard D., Amick, Halle R., Sherwood, Molly R., Dunn, Kelly E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 157
container_issue
container_start_page 148
container_title Journal of substance abuse treatment
container_volume 104
creator Chilcoat, Howard D.
Amick, Halle R.
Sherwood, Molly R.
Dunn, Kelly E.
description Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD. •Most who use illicit buprenorphine do so for reasons related to misuse (eg, manage withdrawal or maintain abstinence from other opioids).•A much smaller percentage of study most respondents reported using illicit buprenorphine for reasons related to abuse (to get high).•There appears to be a gap between need for buprenorphine and access to adequate treatment.
doi_str_mv 10.1016/j.jsat.2019.07.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2268306786</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0740547218304720</els_id><sourcerecordid>2268306786</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-454e7b57f65348ad3de8fc38ce76ddd36443423c7b7a9df2f0d3e72cd13ba1ef3</originalsourceid><addsrcrecordid>eNp9kDtPHDEUha0oKGwgf4ACWUpDkRn8mrEnShNQHkiLKBJqy2PfER7t2hvbg8S_x5slKVKkOsX9ztHVh9AZJS0ltL-c2zmb0jJCh5bIlpDuFVpRJXnTC8VfoxWRgjSdkOwYvc15JoQwRtQbdMwpl2SQwwqtr5ZdghDT7sEHwD7g8gD4PvgCDv8opkD-iG9j8Y-Q8RQTNuOS4QPe-vw7TXDY1WPKPoZTdDSZTYZ3L3mC7r9--Xn9vVnffbu5_rxurGCqNKITIMdOTn3HhTKOO1CT5cqC7J1zvBeCC8atHKUZ3MQm4jhIZh3lo6Ew8RN0cdjdpfhrgVx0fcfCZmMCxCVrxnrFSS9VX9H3_6BzXFKo31VKKjVIJkWl2IGyKeacYNK75LcmPWlK9N61nvXetd671kTq6rqWzl-ml3EL7m_lj9wKfDoAUF08ekg6Ww_BgvMJbNEu-v_tPwOlRI9y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2278897274</pqid></control><display><type>article</type><title>Buprenorphine in the United States: Motives for abuse, misuse, and diversion</title><source>Elsevier ScienceDirect Journals</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><creator>Chilcoat, Howard D. ; Amick, Halle R. ; Sherwood, Molly R. ; Dunn, Kelly E.</creator><creatorcontrib>Chilcoat, Howard D. ; Amick, Halle R. ; Sherwood, Molly R. ; Dunn, Kelly E.</creatorcontrib><description>Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD. •Most who use illicit buprenorphine do so for reasons related to misuse (eg, manage withdrawal or maintain abstinence from other opioids).•A much smaller percentage of study most respondents reported using illicit buprenorphine for reasons related to abuse (to get high).•There appears to be a gap between need for buprenorphine and access to adequate treatment.</description><identifier>ISSN: 0740-5472</identifier><identifier>EISSN: 1873-6483</identifier><identifier>DOI: 10.1016/j.jsat.2019.07.005</identifier><identifier>PMID: 31370979</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Access to care ; Buprenorphine ; Health policy ; Narcotics ; Opioid abuse ; Opioids ; Public health ; Self-treatment ; Withdrawal symptoms</subject><ispartof>Journal of substance abuse treatment, 2019-09, Vol.104, p.148-157</ispartof><rights>2019 The Authors</rights><rights>Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-454e7b57f65348ad3de8fc38ce76ddd36443423c7b7a9df2f0d3e72cd13ba1ef3</citedby><cites>FETCH-LOGICAL-c428t-454e7b57f65348ad3de8fc38ce76ddd36443423c7b7a9df2f0d3e72cd13ba1ef3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0740547218304720$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,30978,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31370979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chilcoat, Howard D.</creatorcontrib><creatorcontrib>Amick, Halle R.</creatorcontrib><creatorcontrib>Sherwood, Molly R.</creatorcontrib><creatorcontrib>Dunn, Kelly E.</creatorcontrib><title>Buprenorphine in the United States: Motives for abuse, misuse, and diversion</title><title>Journal of substance abuse treatment</title><addtitle>J Subst Abuse Treat</addtitle><description>Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD. •Most who use illicit buprenorphine do so for reasons related to misuse (eg, manage withdrawal or maintain abstinence from other opioids).•A much smaller percentage of study most respondents reported using illicit buprenorphine for reasons related to abuse (to get high).•There appears to be a gap between need for buprenorphine and access to adequate treatment.</description><subject>Access to care</subject><subject>Buprenorphine</subject><subject>Health policy</subject><subject>Narcotics</subject><subject>Opioid abuse</subject><subject>Opioids</subject><subject>Public health</subject><subject>Self-treatment</subject><subject>Withdrawal symptoms</subject><issn>0740-5472</issn><issn>1873-6483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp9kDtPHDEUha0oKGwgf4ACWUpDkRn8mrEnShNQHkiLKBJqy2PfER7t2hvbg8S_x5slKVKkOsX9ztHVh9AZJS0ltL-c2zmb0jJCh5bIlpDuFVpRJXnTC8VfoxWRgjSdkOwYvc15JoQwRtQbdMwpl2SQwwqtr5ZdghDT7sEHwD7g8gD4PvgCDv8opkD-iG9j8Y-Q8RQTNuOS4QPe-vw7TXDY1WPKPoZTdDSZTYZ3L3mC7r9--Xn9vVnffbu5_rxurGCqNKITIMdOTn3HhTKOO1CT5cqC7J1zvBeCC8atHKUZ3MQm4jhIZh3lo6Ew8RN0cdjdpfhrgVx0fcfCZmMCxCVrxnrFSS9VX9H3_6BzXFKo31VKKjVIJkWl2IGyKeacYNK75LcmPWlK9N61nvXetd671kTq6rqWzl-ml3EL7m_lj9wKfDoAUF08ekg6Ww_BgvMJbNEu-v_tPwOlRI9y</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Chilcoat, Howard D.</creator><creator>Amick, Halle R.</creator><creator>Sherwood, Molly R.</creator><creator>Dunn, Kelly E.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>K7.</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201909</creationdate><title>Buprenorphine in the United States: Motives for abuse, misuse, and diversion</title><author>Chilcoat, Howard D. ; Amick, Halle R. ; Sherwood, Molly R. ; Dunn, Kelly E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-454e7b57f65348ad3de8fc38ce76ddd36443423c7b7a9df2f0d3e72cd13ba1ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Access to care</topic><topic>Buprenorphine</topic><topic>Health policy</topic><topic>Narcotics</topic><topic>Opioid abuse</topic><topic>Opioids</topic><topic>Public health</topic><topic>Self-treatment</topic><topic>Withdrawal symptoms</topic><toplevel>online_resources</toplevel><creatorcontrib>Chilcoat, Howard D.</creatorcontrib><creatorcontrib>Amick, Halle R.</creatorcontrib><creatorcontrib>Sherwood, Molly R.</creatorcontrib><creatorcontrib>Dunn, Kelly E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of substance abuse treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chilcoat, Howard D.</au><au>Amick, Halle R.</au><au>Sherwood, Molly R.</au><au>Dunn, Kelly E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Buprenorphine in the United States: Motives for abuse, misuse, and diversion</atitle><jtitle>Journal of substance abuse treatment</jtitle><addtitle>J Subst Abuse Treat</addtitle><date>2019-09</date><risdate>2019</risdate><volume>104</volume><spage>148</spage><epage>157</epage><pages>148-157</pages><issn>0740-5472</issn><eissn>1873-6483</eissn><abstract>Opioid use disorder (OUD) and its consequences are a major public health concern. The partial agonist buprenorphine is a safe and effective treatment for OUD, but concerns about abuse, misuse, and diversion of buprenorphine have been raised. This narrative review examined the rates and motives for use of illicit buprenorphine in the United States. Findings from the 17 included studies suggest the majority of study participants using illicit buprenorphine do so for reasons related to misuse (to manage opioid withdrawal symptoms or achieve or maintain abstinence from other opioids). A smaller percentage of study respondents reported using buprenorphine for reasons related to abuse (to get high). There appears to be a gap between need for buprenorphine and access to adequate treatment. Attenuation of policy-related barriers and adoption of appropriate buprenorphine use by the treatment community are critical tools in the continued effort to reduce the burdens associated with OUD. •Most who use illicit buprenorphine do so for reasons related to misuse (eg, manage withdrawal or maintain abstinence from other opioids).•A much smaller percentage of study most respondents reported using illicit buprenorphine for reasons related to abuse (to get high).•There appears to be a gap between need for buprenorphine and access to adequate treatment.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31370979</pmid><doi>10.1016/j.jsat.2019.07.005</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0740-5472
ispartof Journal of substance abuse treatment, 2019-09, Vol.104, p.148-157
issn 0740-5472
1873-6483
language eng
recordid cdi_proquest_miscellaneous_2268306786
source Elsevier ScienceDirect Journals; Applied Social Sciences Index & Abstracts (ASSIA)
subjects Access to care
Buprenorphine
Health policy
Narcotics
Opioid abuse
Opioids
Public health
Self-treatment
Withdrawal symptoms
title Buprenorphine in the United States: Motives for abuse, misuse, and diversion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T03%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Buprenorphine%20in%20the%20United%20States:%20Motives%20for%20abuse,%20misuse,%20and%20diversion&rft.jtitle=Journal%20of%20substance%20abuse%20treatment&rft.au=Chilcoat,%20Howard%20D.&rft.date=2019-09&rft.volume=104&rft.spage=148&rft.epage=157&rft.pages=148-157&rft.issn=0740-5472&rft.eissn=1873-6483&rft_id=info:doi/10.1016/j.jsat.2019.07.005&rft_dat=%3Cproquest_cross%3E2268306786%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2278897274&rft_id=info:pmid/31370979&rft_els_id=S0740547218304720&rfr_iscdi=true